Synthesis and anticancer activity of [1,2,4] triazole [4,3-b] [1,2,4,5] tetrazine derivatives

References

• Liang, X.; Yang, Q.; Wu, P.; He, C.; Yin, L.; Xu, F.; Yin, Z.; Yue, G.; Zou, Y.; Li, L.; et al. The Synthesis Review of the Approved Tyrosine Kinase Inhibitors for Anticancer Therapy in 2015–2020. Bioorg. Chem. 2021, 113, 105011. DOI: 10.1016/j.bioorg.2021.105011.
   PubMed Web of Science ®Google Scholar
• Li, J.; Wang, R.-Q.; Gao, J.-J. Novel Anticancer Drugs Approved in 2020. Drug Discov. Ther. 2021, 15, 44–47. DOI: 10.5582/ddt.2021.01013.
   PubMed Web of Science ®Google Scholar
• Han, Y.; Dong, W.; Guo, Q.-Q.; Li, X.-F.; Huang, L.-Q. The Importance of Indole and Azaindole Scaffold in the Development of Antitumor Agents. Eur. J. Med. Chem. 2020, 203, 112506. DOI: 10.1016/j.ejmech.2020.112506.
   PubMed Web of Science ®Google Scholar
• Tafesse, T.-B.; Bule, M.-H.; Khan, F.; Abdollahi, M.; Amini, M. Developing Novel Anticancer Drugs for Targeted Populations: An Update. Curr. Pharm. Des. 2021, 27, 250–262. DOI: 10.2174/1381612826666201124111748.
   PubMed Web of Science ®Google Scholar
• Ma, Y.-S.; Liu, J.-B.; Yang, X.-L.; Xin, R.; Shi, Y.; Zhang, D.-D.; Wang, H.-M.; Wang, P.-Y.; Lin, Q.-L.; Li, W.; et al. Basic Approaches, Challenges and Opportunities for the Discovery of Small Molecule Anti-Tumor Drugs. Am. J. Cancer Res. 2021, 11, 2386–2400. PMID: 34249406.
   PubMed Web of Science ®Google Scholar
• Khwaza, V.; Mlala, S.; Oyedeji, O.-O.; Aderibigbe, B.-A. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery. Molecules 2021, 26, 2401. DOI: 10.3390/molecules26092401.
   PubMed Web of Science ®Google Scholar
• Gomha, S.-M.; Abdel-Aziz, H.-M.; El-Reedy, A.-A.-M. Facile Synthesis of Pyrazolo[3,4-c]Pyrazoles Bearing Coumarine Ring as Anticancer Agents. J. Heterocyclic Chem. 2018, 55, 1960–1965. DOI: 10.1002/jhet.3235.
   Web of Science ®Google Scholar
• Gomha, S.-M.; Shawali, A.-S.; Abdelhamid, A.-O. Convenient Method for Synthesis of Various Fused Heterocycles via Utility of 4-Acetyl-5-Methyl-1-Phenyl-Pyrazole as Precursor. Turk. J. Chem. 2014, 38, 865–879. DOI: 10.3906/kim-1311-12.
   Web of Science ®Google Scholar
• Gomha, S.-M.; Salah, T.-A.; Abdelhamid, A.-O. Synthesis, Characterization, and Pharmacological Evaluation of Some Novel Thiadiazoles and Thiazoles Incorporating Pyrazole Moiety as Anticancer Agents. Monatsh. Chem. 2015, 146, 149–158. DOI: 10.1007/s00706-014-1303-9.
   Web of Science ®Google Scholar
• Gomha, S.-M.; Edrees, M.-M.; Altalbawy, F.-M.-A. Synthesis and Characterization of Some New Bis-Pyrazolyl-Thiazoles Incorporating the Thiophene Moiety as Potent Anti-Tumor Agents. IJMS 2016, 17, 1499. DOI: 10.3390/ijms17091499.
   Google Scholar
• Gomha, S.-M.; Edrees, M.-M.; Faty, R.-A.-M.; Muhammad, Z.-A.; Mabkhot, Y.-N. Microwave-Assisted One Pot Three-Component Synthesis of Some Novel Pyrazole Scafolds as Potent Anticancer Agents. Chem. Cent. J. 2017, 11, 37. DOI: 10.1186/s13065-017-0266-4.
   PubMed Web of Science ®Google Scholar
• Abdallah, M.-A.; Gomha, S.-M.; Abbas, I.-M.; Kazem, M.-S.-H.; Alterary, S.-S.; Mabkhot, Y.-N. An Efficient Synthesis of Novel Pyrazole-Based Heterocycles as Potential Antitumor Agents. Appl. Sci. 2017, 7, 785. DOI: 10.3390/app7080785.
   Google Scholar
• Gomha, S.-M.; Abdallah, M.-A.; Abbas, I.-M.; Kazem, M.-S.-H. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety. Med. Chem. 2018, 14, 344–355. DOI: 10.2174/1573406413666171020114105.
   PubMed Web of Science ®Google Scholar
• Chen, F.; Wang, Y.; Ai, J.; Zhan, Z.; Lv, Y.; Liang, Z.; Luo, C.; Mei, D.; Geng, M.; Duan, W.; et al. O-Linked Triazolotriazines: Potent and Selective c-Met Inhibitors. ChemMedChem 2012, 7, 1276–1285. DOI: 10.1002/cmdc.201200145.
   PubMed Web of Science ®Google Scholar
• Xu, F.; Yang, Z.-Z.; Ke, Z.-L.; Xi, L.-M.; Yan, Q.-D.; Yang, W.-Q.; Zhu, L.-Q.; Lin, F.-L.; Lv, W.-K.; Wu, H.-G.; et al. Synthesis, Antitumor Evaluation and 3D-QSAR Studies of [1,2,4]Triazolo[4,3-b][1,2,4,5]Tetrazine Derivatives. Bioorg. Med. Chem. Lett. 2016, 26, 4580–4586. DOI: 10.1016/j.bmcl.2016.08.078.
   PubMedGoogle Scholar
• Xu, F.; Yang, Z.-Z.; Jiang, J.-R.; Pan, W.-G.; Yang, X-l.; Wu, J.-Y.; Zhu, Y.; Wang, J.; Shou, Q.-Y.; Wu, H.-G.; et al. Synthesis, Antitumor Evaluation and Molecular Docking Studies of [1,2,4]Triazolo[4,3-b][1,2,4,5]Tetrazine Derivatives. Bioorg. Med. Chem. Lett. 2016, 26, 3042–3047. DOI: 10.1016/j.bmcl.2016.05.007.
   PubMedGoogle Scholar
• Shi, R.-J.; Yang, Z.-Z.; Gao, Y.-T.; Cai, W.-J.; Ye, C.; Xu, F.; Wang, J. Synthesis and Biological Evaluation of Novel 6-Alkoxy-3-Aryl-[1,2,4]Triazolo[4,3-b][1,2,4,5]Tetrazines. J. Chem. Res. 2019, 43, 313–318. DOI: 10.1177/1747519819861865.
   Web of Science ®Google Scholar
• Xu, F.; Yang, Z.-Z.; Jiang, J.-R.; Ke, Z.-L. Syntheses and Crystal Structures of Two Unsymmetrical 1,2,4,5-Tetrazine Derivatives. J. Chem. Crystallogr. 2012, 42, 600–605. DOI: 10.1007/s10870-012-0287-8.
   Web of Science ®Google Scholar
• Chavez, D.-E.; Hiskey, M.-A. Synthesis of the bi-Heterocyclic Parent Ring System 1,2,4-Triazolo[4,3-b][1,2,4,5]Tetrazine and Some 3,6-Disubstituted Derivatives. J. Heterocyclic. Chem. 1998, 35, 1329–1332. DOI: 10.1002/jhet.5570350616.
   Web of Science ®Google Scholar
• Glidewell, C.; Lightfoot, P.; Royles, B.-J.-L.; Smith, D.-M. The ‘Inverse Electron-Demand’ Diels–Alder Reaction in Polymer Synthesis. Part 4.1 the Preparation and Crystal Structures of Some Bis(1,2,4,5-Tetrazines). J. Chem. Soc., Perkin Trans. 2 1997, 1167–1174. DOI: 10.1039/a607646g.
   Google Scholar
• Rusinov, G.-L.; Ganebnykh, I.-N.; Chupakhin, O.-N. Synthesis of Triazolo[4,3-b][1,2,4,5]Tetrazines. Russ. J. Org. Chem. 1999, 35, 1350–1354.
   Google Scholar
• Ohno, M.; Abe, T. Rapid Colorimetric Assay for the Quantification of Leukemia Inhibitory Factor (LIF) and Interleukin-6 (IL-6). J. Immunol. Methods 1991, 145, 199–203. DOI: 10.1016/0022-1759(91)90327-C.
   PubMed Web of Science ®Google Scholar